Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Basel Medical GroupBMGL +23.65%17 Equity-to-Asset is 0.31 as of Dec. 2025, which is 14% below its 10-year median of 0.36. GuruFocus rates BMGL with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Basel Medical Group ranks worse than 71.14% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Basel Medical Group's Total Stockholders Equity for the quarter that ended in Dec. 2025 was $4.87 Mil. Basel Medical Group's Total Assets for the quarter that ended in Dec. 2025 was $15.59 Mil.
Therefore, Basel Medical Group's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was 0.31.
The historical rank and industry rank for Basel Medical Group's Equity-to-Asset or its related term are showing as below:
BMGL'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.22 Med: 0.36 Max: 0.49
Current: 0.31
During the past 4 years, the highest Equity to Asset Ratio of Basel Medical Group was 0.49. The lowest was 0.22. And the median was 0.36.
BMGL's Equity-to-Asset is ranked worse than 71.14% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs BMGL: 0.31
Basel Medical Group (NAS:BMGL) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Basel Medical Group Equity-to-Asset Related Terms
Basel Medical Group Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Basel Medical Group's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BMGL vs BICX, SYRA, AMS: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Basel Medical Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Basel Medical Group Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Basel Medical Group's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Basel Medical Group's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Basel Medical Group's Equity to Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Basel Medical Group (BMGL) has a Equity-to-Asset of 0.31 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Basel Medical Group and its competitors. This is 14% below median its historical median of 0.36. Over the past decade, Basel Medical Group's Equity-to-Asset has ranged from 0.22 to 0.49. According to the industry distribution chart, Basel Medical Group ranks #488 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 71.1%.
Is Basel Medical Group's Equity-to-Asset too high?
Basel Medical Group's current Equity-to-Asset of 0.31 is 14% below median its 10-year median of 0.36. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 0.49. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Basel Medical Group's value of 0.31 is 35.4% below this industry median. Based on the distribution chart, Basel Medical Group ranks #488 out of 686 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Basel Medical Group has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Basel Medical Group's Equity-to-Asset compare to BICX and SYRA?
According to the Healthcare Providers & Services industry distribution chart, Basel Medical Group ranks #488 out of 686 companies for Equity-to-Asset. This places Basel Medical Group in the lower half of its industry. The industry median Equity-to-Asset is 0.48. Basel Medical Group's value of 0.31 is 35.4% below this benchmark. Historically, Basel Medical Group's own Equity-to-Asset has ranged from 0.22 to 0.49 over the past decade. While the company's 10-year median is 0.36 vs. the industry median of 0.48, Basel Medical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Basel Medical Group's current Equity-to-Asset of 0.31 is 35.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Basel Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Basel Medical Group's current Equity-to-Asset is 0.31, which is 14% below median its own 10-year median of 0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basel Medical Group stock overvalued right now?
Basel Medical Group (BMGL) has a current Equity-to-Asset of 0.31. The current Equity-to-Asset is 0.31, which is 14% below median its 10-year median of 0.36 and 35.4% below the Healthcare Providers & Services industry median of 0.48. Basel Medical Group's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Basel Medical Group (BMGL), the current Equity-to-Asset is 0.31 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
17GF Score
Get the complete analysis for BMGL
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMGL has been successfully added to your 
